Anzeige
Mehr »
Mittwoch, 23.09.2026 - Börsentäglich über 12.000 News
Der Markt ist gerade aufgewacht: Atlantico Energy Metals steigt um 100 %
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PLSH | ISIN: JE00BJJN4441 | Ticker-Symbol: 16A
München
22.09.26 | 08:01
1,642 Euro
+0,37 % +0,006
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
CLARIVATE PLC Chart 1 Jahr
5-Tage-Chart
CLARIVATE PLC 5-Tage-Chart
RealtimeGeldBriefZeit
1,6801,70022.09.

Aktuelle News zur CLARIVATE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiClarivate Plc: Clarivate to Report Third Quarter 2026 Results on November 3, 2026172LONDON, Sept. 22, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the third...
► Artikel lesen
DoClarivate-Tochter startet Rückkaufangebot für Anleihen mit Fälligkeit 20286
DoClarivate unit launches tender offer for 2028 notes2
DoClarivate Plc: Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities1.376NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate...
► Artikel lesen
DoCLARIVATE PLC - 8-K, Current Report2
DoClarivate Plc: Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs31722 researchers honored for Nobel-class discoveries, including pioneers of GLP-1 medicines and other world-changing advancesLONDON, Sept. 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a...
► Artikel lesen
06.08.Clarivate Plc: Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development774Expanded capabilities across Cortellis portfolio help life sciences organizations turn trusted intelligence into action and accelerate decision making across the research and development...
► Artikel lesen
29.07.Clarivate expects about $900M debt reduction in 2026 as it targets nearly 43% adjusted EBITDA margin1
CLARIVATE Aktie jetzt für 0€ handeln
29.07.Clarivate meldet Umsatzrückgang im zweiten Quartal aufgrund von Veräußerungen1
29.07.Clarivate appoints Michael Easton as chief financial officer1
29.07.Clarivate Analytics Non-GAAP EPS of $0.19 beats by $0.01, revenue of $587.3M misses by $2.46M3
29.07.Clarivate Plc: Clarivate Reports Second Quarter 2026 Results4.283- Delivers continued progress on strategic and financial priorities through Value Creation Plan -- Sharpens focus and enhances financial profile with previously announced Life Sciences &...
► Artikel lesen
29.07.Clarivate Plc: Clarivate Appoints Michael Easton as Chief Financial Officer607Experienced Clarivate leader brings more than 25 years of financial and operational expertiseLONDON, July 29, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate" or the "Company")...
► Artikel lesen
29.07.CLARIVATE PLC - 10-Q, Quarterly Report5
29.07.CLARIVATE PLC - 8-K, Current Report3
28.07.Clarivate Analytics Q2 2026 Earnings Preview2
16.07.Clarivate Plc: USPTO Launches AI Image Search in Trademark Search System, Powered by Clarivate503LONDON, July 16, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, is proud to support the U.S. Patent and Trademark Office (USPTO)...
► Artikel lesen
14.07.Clarivate Selected by Abes to Modernize French National Academic Library System3
10.07.Clarivate Plc: Clarivate to Report Second Quarter 2026 Results on July 29, 2026371LONDON, July 10, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the second...
► Artikel lesen
08.07.Clarivate Selling Life Sciences & Healthcare Segment To Altaris For $600 Million1
Weiter >>
82 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1